Amneal launches Biosciences unit to market generic, specialty drugs
Amneal said on Tuesday that it has created Amneal Biosciences, a wholly owned subsidiary of Amneal Pharmaceuticals LLC. Amneal Biosciences will focus on the commercialization of high-barrier-to-entry generic and specialty pharmaceuticals, such as injectables, oncologics and biosimilars. Read More »